NO941785L - Triazin-derivater for ökning av anti-tumor aktivitet - Google Patents

Triazin-derivater for ökning av anti-tumor aktivitet

Info

Publication number
NO941785L
NO941785L NO941785A NO941785A NO941785L NO 941785 L NO941785 L NO 941785L NO 941785 A NO941785 A NO 941785A NO 941785 A NO941785 A NO 941785A NO 941785 L NO941785 L NO 941785L
Authority
NO
Norway
Prior art keywords
tumor activity
triazine derivatives
increasing anti
increasing
triazine
Prior art date
Application number
NO941785A
Other languages
English (en)
Norwegian (no)
Other versions
NO941785D0 (no
Inventor
Jotham Wadsworth Coe
Anton Franz J Fliri
Takushi Kaneko
Eric Robert Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO941785D0 publication Critical patent/NO941785D0/no
Publication of NO941785L publication Critical patent/NO941785L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO941785A 1991-11-12 1994-05-11 Triazin-derivater for ökning av anti-tumor aktivitet NO941785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79078991A 1991-11-12 1991-11-12
PCT/US1992/007656 WO1993010116A1 (en) 1991-11-12 1992-09-16 Triazine derivatives for enhancing antitumor activity

Publications (2)

Publication Number Publication Date
NO941785D0 NO941785D0 (no) 1994-05-11
NO941785L true NO941785L (no) 1994-05-11

Family

ID=25151750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941785A NO941785L (no) 1991-11-12 1994-05-11 Triazin-derivater for ökning av anti-tumor aktivitet

Country Status (14)

Country Link
US (1) US5536722A (pt)
EP (1) EP0613477A1 (pt)
JP (1) JPH07506084A (pt)
AU (1) AU2599992A (pt)
CA (1) CA2123402A1 (pt)
FI (1) FI942188A0 (pt)
HU (1) HUT69722A (pt)
IL (1) IL103655A0 (pt)
MX (1) MX9206468A (pt)
NO (1) NO941785L (pt)
PT (1) PT101046A (pt)
TW (1) TW208004B (pt)
WO (1) WO1993010116A1 (pt)
ZA (1) ZA928683B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311614B1 (no) 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
WO1999036410A1 (en) * 1998-01-13 1999-07-22 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US6335339B1 (en) * 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
GB2336839A (en) * 1998-04-30 1999-11-03 Sharp Kk Triazine Compounds And Their Use In Electrolumiescent, Electronic and Liquid Crystal Devices
US6881740B1 (en) 1998-07-08 2005-04-19 Monash University Pharmaceutical agents
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
DK1183245T3 (da) * 1999-04-22 2007-09-24 Lundbeck & Co As H Selektive NPY(Y5)-antagonister
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7273880B2 (en) * 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US7045247B1 (en) * 2000-08-24 2006-05-16 The Gillette Company Battery cathode
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP2046763A2 (en) * 2006-07-31 2009-04-15 Praecis Pharmaceuticals Incorporated Aurora kinase inhibitors from an encoded small molecule library
ES2621932T3 (es) 2010-10-27 2017-07-05 The Walter And Eliza Hall Institute Of Medical Research Agentes antineoplásicos novedosos
KR101472083B1 (ko) * 2012-10-22 2014-12-16 광주과학기술원 ＥＮＯｂｌｏｃｋ을 유효성분으로 포함하는 암 예방 또는 치료용 약제학적 조성물
JP2019064976A (ja) * 2017-10-03 2019-04-25 国立大学法人 熊本大学 抗がん剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
DE68920798T2 (de) * 1988-08-19 1995-05-18 Warner Lambert Co Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren.
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
DK0556310T3 (da) * 1990-11-06 1995-08-21 Pfizer Quinazolinderivater til forhøjelse af antitumoraktivitet
FR2673627B1 (fr) * 1991-03-07 1993-05-07 Adir Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
US5536722A (en) 1996-07-16
TW208004B (pt) 1993-06-21
NO941785D0 (no) 1994-05-11
EP0613477A1 (en) 1994-09-07
FI942188L (fi) 1994-05-11
CA2123402A1 (en) 1993-05-27
FI942188A7 (fi) 1994-05-11
FI942188A0 (fi) 1994-05-11
HU9401385D0 (en) 1994-08-29
AU2599992A (en) 1993-06-15
IL103655A0 (en) 1993-04-04
ZA928683B (en) 1994-05-11
HUT69722A (en) 1995-09-28
PT101046A (pt) 1994-02-28
MX9206468A (es) 1993-05-01
JPH07506084A (ja) 1995-07-06
WO1993010116A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
NO941785D0 (no) Triazin-derivater for ökning av anti-tumor aktivitet
DE69208877D1 (de) Chinuclidinderivate
FI924160A7 (fi) Benzanilidderivat
FI935726A7 (fi) Atsanorbornaanijohdannaisia
FI924159L (fi) Benzanilidderivat
NO922182L (no) Krystallinske oksatiolan-derivater
FI924054L (fi) Iso- och heterocykliska foereningar kopplade med imidazol, foerfarande foer framstaellning av dessa och anvaendning av dessa
FI922481A7 (fi) Heterosyklisiä johdannaisia
DE59208415D1 (de) 3-Hydroxy-4-aryl-5-oxo-pyrazolin Derivate
FI935074L (fi) Nya tiopyranopyrrolderivat och framstaellning av dem
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
FI930345L (fi) Foerfarande foer framstaellning av renat akrylamidosulfonsyramonomerderivat
LV11176A (lv) Uracila atvasinajumi
DE69121334D1 (de) DC-89-Derivate als Antitumor-Wirkstoffe
FI935243L (fi) Pyridonkarboxylsyraderivat
FI924779L (fi) N-fenyl-2-cyano-3-hydroxikrotonsyraamidderivat och anvaendning av dessasom laekemedel med en immunomodulerande egenskap
FI934565L (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
FI920394A7 (fi) 3-kinuklidiinijohdannaiset
IT9019840A0 (it) Composti triazinici
MX9206710A (es) Derivados de piridinol
FI924145L (fi) 3-cykloalkylprop-2-enamidderivat
NO924532D0 (no) Fremgangsmaate for fremstilling av triazinderivater
FI922694L (fi) Tioxantenonderivat med antitumoereffekt
FI942070A7 (fi) Nitroksialkyyliamidijohdannaiset